av/lianbio--big.svg

NASDAQ:LIAN

LianBio

  • Stock

USD

Last Close

0.32

16/01 21:00

Market Cap

34.47M

Beta: -

Volume Today

2.49M

Avg: 224.13K

PE Ratio

−4.99

PFCF: −5.23

OverviewFinancialsAPI
Income StatementBalance SheetCash FlowKey MetricsRatios
Excel Tearsheet
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
-3.02M
-
-3.02M
0%
average payables
2.16M
-
3.78M
74.64%
2.34M
38.04%
average receivables
10.13M
-
13.15M
29.83%
3.91M
70.29%
book value per share
-1.26
-
10.28
914.49%
2.41
76.58%
capex per share
-0.01
-
-0.03
227.10%
-0.02
37.91%
capex to depreciation
-11.66
-
-1.80
84.53%
-1.83
1.67%
capex to operating cash flow
0.01
-
0.01
36.02%
0.02
222.05%
capex to revenue
cash per share
2.42
-
11.14
361.12%
2.80
74.86%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.01
-
0.01
44.48%
0.01
68.44%
0.01
19.60%
debt to equity
-0.03
-
-0.01
57.93%
0.01
196.61%
0.02
22.12%
dividend yield
earnings yield
-0.10
-
-0.93
857.02%
-0.62
32.74%
enterprise value
-42.77M
-
1.19B
2,881.40%
-11.48M
100.96%
102.11M
989.70%
enterprise value over ebitda
-8.83
-
0.06
100.66%
-0.81
1,488.07%
ev to operating cash flow
-12.12
-
0.07
100.58%
-1.03
1,570.68%
ev to sales
free cash flow per share
-0.94
-
-4.79
409.59%
-0.94
80.47%
free cash flow yield
-0.07
-
-0.78
1,033.35%
-0.57
26.66%
graham net net
-1.02
-
10.05
1,081.45%
2.57
74.43%
graham number
6.14
-
36.33
492.02%
7.44
79.52%
income quality
0.70
-
0.84
18.81%
0.90
7.67%
intangibles to total assets
0
-
0
0
0
interest coverage
-804.81
-
8.51
101.06%
interest debt per share
0.02
-
0.15
726.44%
-0.10
165.23%
inventory turnover
invested capital
-0.03
-
-0.01
57.93%
0.01
196.61%
0.02
22.12%
market cap
1.44B
-
211.87M
85.31%
176.99M
16.46%
net current asset value
-15.35M
-
-100.61M
555.53%
360.64M
458.45%
286.46M
20.57%
net debt to ebitda
1.87
-
1.14
39.03%
0.60
47.69%
net income per share
-1.33
-
-5.71
330.31%
-1.02
82.09%
operating cash flow per share
-0.93
-
-4.77
411.24%
-0.92
80.72%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-0.50
-
-0.46
7.89%
-0.34
25.13%
revenue per share
roe
1.05
-
-0.56
152.83%
-0.42
23.56%
roic
1.04
-
-0.54
151.67%
-0.47
13.80%
sales general and administrative to revenue
shareholders equity per share
-1.26
-
10.28
914.49%
2.41
76.58%
stock based compensation to revenue
tangible asset value
-14.82M
-
-98.07M
561.92%
387.34M
494.96%
293.65M
24.19%
tangible book value per share
-0.93
-
11.26
1,308.68%
2.72
75.84%
working capital
40.00M
-
270.52M
576.27%
384.56M
42.15%
289.16M
24.81%

All numbers in USD (except ratios and percentages)